Clinical Trial Update: Pimecrolimus Cream 1% in Adult Patients With Perioral Dermatitis [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating pimecrolimus cream 1% for adult perioral dermatitis has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Perioral Dermatitis

Drugs mentioned

• Pimecrolimus Cream 1% (pimecrolimus)

Snippet

Sponsor: Novartis | Conditions: Perioral Dermatitis | Phase 3 | Status: COMPLETED